| ¿µ¹® | sodium | ÇÑ±Û | ³ªÆ®·ý |
|---|---|---|---|
| ¼³¸í | ¿øÀÚ¹øÈ£ 11ÀÇ ±Ý¼Ó¿øÀÚ. ¼¼Æ÷ ¿Ü¾×ÀÇ °¡Àå ÈçÇÑ ¾çÀÌ¿ÂÀ¸·Î¼ ¼¼Æ÷ ¿Ü¾×ÀÇ »ïÅõ¾Ð°áÁ¤¿¡ °¡Àå Áß¿äÇÑ ¿ªÇÒÀ» ÇÔ. ¾Ëµµ½ºÅ×·Ð(aldosterone: ÄáÆÏÀ§¿¡ ÀÖ´Â ºÎ½Å¿¡¼ ºÐºñÇÑ´Ù. Ç÷¾×³»ÀÇ »ïÅõ¾ÐÀ¯Áö¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù)¿¡ ÀÇÇØ ÄáÆÏ¿¡¼ ÀçÈí¼ö°¡ ÃËÁøµÇ¸ç ü³» ¼öºÐ·®À» °áÁ¤ÇÏ´Â °¡Àå Áß¿äÇÑ ÀÎÀÚ. ½Å°æ¼¼Æ÷ µîÀÇ ÈïºÐ¼º ¼¼Æ÷ÀÇ ÈïºÐ½Ã ¼¼Æ÷³»·Î À¯ÀԵǾî ÈïºÐÀ» À¯¹ßÇÏ´Â Áß¿äÇÑ ±â´Éµµ °¡Áø´Ù. |
||
| ¿µ¹® | beta-blocker | ÇÑ±Û | º£Å¸Â÷´ÜÁ¦ |
|---|---|---|---|
| ¼³¸í | º£Å¸-¼ö¿ëü(1°ú 2¿¡ °ü°è¾øÀÌ)ÀÇ ±â´ÉÀ» ¾ïÁ¦½ÃŰ´Â ¾à¹°·Î ÀÌ ¼ö¿ëü°¡ ¸Å°³ÇÏ¿© »ý±â´Â ½ÅüÀÇ º¯È¸¦ ¾ïÁ¦ÇÑ´Ù. PropranololÀÌ ÁÁÀº ¿¹ÀÌ´Ù. |
||
| Ca2+-blocker | calcium channel blocker |
|---|---|
| CCB | calcium channel blocker |
| DHPCCB | dihydropyridine calcium channel blocker |
| NDHPCCB | non-dihydropyridine calcium channel blocker |
| SCN1A | sodium channel, neuronal alpha-subunit type 1 |
| CCB | Calcium channel blocker |
|---|---|
| KATP channel | ATP sensitive potassium channel |
| BK channel | K channel |
| VGSC | voltage-gated sodium channel |
| ARB | angiotensin receptor blocker |
channel-shoulder-pin attachment
| calcium channel-blocker | <pharmacology> A class of drugs that act by selective inhibition of calcium ion influx through or across cell membranes or on the release and binding of calcium in intracellular pools. Calcium channel blockers are used primarily in the treatment of certain heart conditions and stroke. As they are inducers of vascular and other smooth muscle relaxation, they are also used in the treatment of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms. Synonym: calcium antagonist, calcium channel-blocker, slow channel-blocking agent. (12 May 2002) |
|---|---|
| sodium channel | <neurology, physiology> The protein responsible for electrical excitability of neurons. A transmembrane ion channel, containing an aqueous pore around 0.4nm diameter, with a negatively charged region internally (the selectivity filter) to block passage of anions. The channel is voltage gated: it opens in response to a small depolarisation of the cell (usually caused by an approaching action potential), by a multistep process. Around 1000 sodium ions pass in the next millisecond, before the channel spontaneously closes (an event with single step kinetics). The channel is then refractory to further depolarisations until returned to near the resting potential. There are around 100 channels per square micron in unmyelinated axons, in myelinated axons, they are concentrated at the nodes of Ranvier. The sodium channel is the target of many of the deadliest neurotoxins. (18 Nov 1997) |
| alpha-blocker | An agent that competitively blocks alpha-adrenergic receptors; used in the treatment of hypertension. Synonym: alpha-blocker. (05 Mar 2000) |
| beta-blocker | <pharmacology> A large group of medications that act to block specific receptors in the nervous system. A drug that induces adrenergic blockade at either á1 or á2 adrenergic receptors or at both. The effect of beta-blockade results in slowing of the heart rate, reduction in blood pressure and reduced anxiety. Beta-blockers are used in the treatment of angina, heart arrhythmias, high blood pressure, mitral valve prolapse and other conditions. (06 Oct 1997) |
| blocker | 1. An instrument used to obstruct a passage. See: blocking agent. (05 Mar 2000) |
| medication, beta-blocker | Drugs that antagonise the action of adrenaline (a beta adrenergic substance) and relieve stress to the heart muscle. Beta-blockers are often used to slow the heart rate or lower the blood pressure. (12 Dec 1998) |
| H2 blocker | <pharmacology> A class of anti-ulcer medication which work through the inhibition of basal and nocturnal gastric acid secretion by competitive inhibition of the action of histamine at histamine H2 receptor sites on the parietal cells. Drugs of this type block gastric acid secretion and are therefore clinically useful in treating duodenal ulcers. Examples include cimetidine (Tagamet), famotidine (Pepcid), nizatidine (Axid) and ranitidine (Zantac). (27 Sep 1997) |
| calcium channel | <physiology> A membrane channel that is specific for calcium. It is a voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorised as l, t, n, or p types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. (12 May 2002) |
| calcium channel agonist | <pharmacology> Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture. (12 Dec 1998) |
| calcium channel antagonist | <pharmacology> A class of drugs that act by selective inhibition of calcium ion influx through or across cell membranes or on the release and binding of calcium in intracellular pools. Calcium channel blockers are used primarily in the treatment of certain heart conditions and stroke. As they are inducers of vascular and other smooth muscle relaxation, they are also used in the treatment of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms. Synonym: calcium antagonist, calcium channel-blocker, slow channel-blocking agent. (12 May 2002) |
| gated ion channel | <physiology> Transmembrane proteins of excitable cells, that allow a flux of ions to pass only under defined circumstances. Channels may be either voltage gated, such as the sodium channel of neurons or ligand gated such as the acetylcholine receptor of cholinergic synapses. Channels tend to be relatively ion specific and allow fluxes of typically 1000 ions to pass in around 1ms, they are thus much faster at moving ions across a membrane than transport ATPases. (05 May 1997) |
| voltage-gated channel | A class of ion channel's that open and close in response to change in the electrical potential across the plasma membrane of the cell; voltage-gated Na+ c.'s are important for conducting action potential along nerve cell processes. (05 Mar 2000) |
| voltage gated ion channel | <physiology> A transmembrane ion channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. These channels are essential for neuronal signal transmission and for intracellular signal transduction. See: sodium channel. (18 Nov 1997) |
| channel | A furrow, gutter, or groovelike passageway. See: canal. Origin: L. Canalis (05 Mar 2000) |
| channel forming ionophore | <chemistry> An ionophore that makes an amphipathic pore with hydrophobic exterior and hydrophilic interior. most known types are cation selective. (18 Nov 1997) |
Synonyms : Potassium Sparing Diuretics, Diuretics, Potassium Sparing
| sodium channel blocker |
any of a class of antiarrhythmic agents that prevent ectopic beats by acting on partially inactivated sodium channels to inhibit abnormal depolarizations.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|